WS #10131
FDA advisers voted in favor of Moderna's flu vaccine, driving a 30% surge in MRNA shares and lifting the MRNX ETF over 60%.
Moderna Flu Vaccine FDA Advisory Vote
FDA advisers voted in favor of Moderna's flu vaccine, driving a 30% surge in MRNA shares and lifting the MRNX ETF over 60%.